| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―Sep―18 |
Myositis after SARS-CoV-2 vaccination occurs more frequently than assumed and is probably causally related |
J. Finsterer, A.S. MohanaSundaram, F. Scorza |
| 2 |
[GO] |
2023―Sep―18 |
Response to: myositis after SARS-CoV-2 vaccination occurs more frequently than assumed and is probably causally related |
H. Quiñones-Moya, A. Camargo-Coronel, M.R. Hernández-Zavala |
| 3 |
[GO] |
2023―Jul―17 |
Trends in severe outcomes in SARS-CoV-2-positive hospitalized patients with rheumatic diseases: a monocentric observational and case-control study in northern Italy |
N. Ughi, D.P. Bernasconi, C. Gagliardi, F. Del Gaudio, A. Dicuonzo, A. Maloberti, et al. (+4) C. Giannattasio, C. Rossetti, M.G. Valsecchi, O.M. Epis |
| 4 |
[GO] |
2023―May―08 |
Idiopathic inflammatory myopathies linked to vaccination against SARS-CoV-2: a systematic review |
A. Camargo-Coronel, H. Quiñones-Moya, M.R. Hernández-Zavala, J.R. Hernández-Vázquez, M.Á. Vázquez-Zaragoza |
| 5 |
[GO] |
2023―Mar―21 |
Emerging nailfold capillaroscopic patterns in COVID-19: from acute patients to survivors |
M. Cutolo, A. Sulli, V. Smith, E. Gotelli |
| 6 |
[GO] |
2022―Dec―29 |
Comment to: Disseminated cutaneous herpes simplex, COVID-19 vaccination and rheumatoid arthritis patient: a case report and review |
B. Joob, V. Wiwanitkit |
| 7 |
[GO] |
2022―Sep―13 |
Disseminated cutaneous herpes simplex infection after COVID-19 vaccination in a rheumatoid arthritis patient: a case report and review |
D. Mohamadzadeh, S. Assar, M. Pournazari, P. Soufivand, S. Danaei |
| 8 |
[GO] |
2022―Sep―13 |
Patients with systemic lupus erythematosus and their experience with vaccination against COVID-19: a descriptive and explanatory study |
F. Ceccarelli, V. Covelli, G. Olivieri, F. Natalucci, C. Alessandri, F. Conti |
| 9 |
[GO] |
2022―May―03 |
COVID-19 as potential aggravating factor for the natural course of new onset-dermatomyositis |
M.S.M.S. Faria, S.K. Shinjo |
| 10 |
[GO] |
2022―May―03 |
Erythema nodosum after COVID-19 vaccine |
B. Maranini, G. Ciancio, M. Corazza, F. Ruffilli, G. Galoppini, M. Govoni |
| 11 |
[GO] |
2022―May―03 |
Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab |
J. Finsterer |
| 12 |
[GO] |
2022―May―03 |
Reply to: “Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab” by Josef Finsterer |
B. Maranini, G. Ciancio, R. Cultrera, M. Govoni |
| 13 |
[GO] |
2022―Feb―07 |
Successful treatment of COVID-19 induced neutrophilic myositis with intravenous immunoglobulin and corticosteroids: a case report |
S. Assar, M. Pournazari, P. Soufivand, D. Mohamadzadeh |
| 14 |
[GO] |
2022―Feb―07 |
Multisystemic inflammatory syndrome related to COVID-19, with latent tuberculosis in bone marrow, and satisfactory response to tocilizumab, in a 7-year-old boy |
Z. Morel, R. Suarez, E. Avalos, S. Velázquez, F. Martínez, V. Lezcano, et al. (+4) N. Astigarraga, C. Ghezzi, S. Brizuela, G. Samudio |
| 15 |
[GO] |
2021―Nov―23 |
Herpes zoster infection following mRNA COVID-19 vaccine in a patient with ankylosing spondylitis |
B. Maranini, G. Ciancio, R. Cultrera, M. Govoni |
| 16 |
[GO] |
2021―Apr―20 |
Children with Kawasaki disease or Kawasaki-like syndrome (MIS-C/PIMS) at the time of COVID-19: are they all the same? Case series and literature review |
A. Marino, T. Varisco, G. Quattrocchi, A. Amoroso, D. Beltrami, S. Venturiello, et al. (+5) A. Ripamonti, A. Villa, M. Andreotti, M. Ciuffreda, R. Cimaz |
| 17 |
[GO] |
2021―Apr―20 |
Axial and peripheral spondyloarthritis triggered by sars-cov-2 infection: a report of two cases |
G. El Hasbani, A. Jawad, I. Uthman |
| 18 |
[GO] |
2021―Jan―18 |
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) |
G. Adami, A. Giollo, A. Fassio, C. Benini, E. Bertoldo, F. Bertoldo, et al. (+9) G. Orsolini, L. Idolazzi, O. Viapiana, S. Giannini, G. Passeri, E. Tacconelli, C. Micheletto, D. Gatti, M. Rossini |
| 19 |
[GO] |
2020―Nov―19 |
COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with? |
Z. Ahmadinejad, R. Assari, N. Ayoobi Yazdi, S.-H. Mazloomi, P. Javanshayani, H. Khalili Afousi, V. Ziaee |
